share_log

Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method

Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method

以大麻股爲重點的愛文思控股擁有這種先進的醫療大麻輸送方式
Benzinga ·  06/21 00:15

Cannabinoids-based pharmaceutical company MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) announced on Thursday that it has entered into a licensing agreement with Remidose Aerosols Inc. to acquire the exclusive rights for advanced cannabis products.

總部位於大麻素的製藥公司MediPharm Labs Corp.(多倫多證券交易所股票代碼:LABS)(OTCQB: MIF)(FSE: MLZ)週四宣佈,它已與Remidose Aerosols Inc.簽訂許可協議,收購先進大麻產品的專有權。

Under the deal, current Remidose customers will be serviced through MediPharm starting August 2024, including Canadian direct-to-patient medical platforms and international medical distributors.

根據該協議,從2024年8月起,Remidose的現有客戶將通過MediPharm獲得服務,包括加拿大直接面向患者的醫療平台和國際醫療分銷商。

MediPharm intends to utilize its existing GMP infrastructure, customer channels and wellness sales expertise to expand the customer base of these advanced products in Canada and internationally.

MediPharm打算利用其現有的GMP基礎設施、客戶渠道和健康銷售專業知識,擴大這些先進產品在加拿大和國際上的客戶群。

See also: Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position'

另見:專注於大麻素的製藥公司MediPharm預計第一季度收入將增加,首席財務官吹捧 “強勁的財務狀況”

Learn more about innovation in cannabis at the upcoming Benzinga cannabis event. The 19th Benzinga Cannabis Capital Conference, returns to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.

在即將舉行的Benzinga大麻活動中了解有關大麻創新的更多信息。第19屆Benzinga大麻資本會議將於10月8日至9日重返芝加哥。點擊此鏈接,立即在價格飆升之前獲取門票。

The products in question are split into two main categories, including:

相關產品分爲兩個主要類別,包括:

  • Metered Dose Inhalers. Why? Used in the pharmaceutical industry as well, this inhalation format provides rapid onset without the adverse effects of smoking.
  • Pressurized Sublingual Sprays. Why? Providing users with an accurate and repeatable experience, this aerosol delivery method has a faster onset, better bioavailability and a more pleasant taste and feel.
  • 計量吸入器。爲什麼?這種吸入形式也用於製藥行業,可快速起病,不會產生吸菸的不良影響。
  • 加壓舌下噴霧。爲什麼?這種氣溶膠輸送方法爲用戶提供準確和可重複的體驗,具有更快的起效速度、更好的生物利用度以及更令人愉悅的味道和感覺。

"MediPharm Labs is committed to providing access to non-smokeable, precision-dosed formats for cannabis patients and wellness consumers," David Pidduck, CEO of MediPharm said. "This agreement, in addition to bringing immediate revenue, opens many new potential global medical opportunities."

MediPharm首席執行官戴維·皮德杜克說:“MediPharm Labs致力於爲大麻患者和健康消費者提供不可吸菸、精確劑量的藥劑。”“該協議除了帶來即時收入外,還開闢了許多新的潛在全球醫療機會。”

MediPharm already has the requisite equipment and GMP facility for these product lines to be manufactured in-house with no material incremental capital costs.

MediPharm已經擁有必要的設備和GMP設施,可以在內部製造這些產品線,而無需增加任何實質性的資本成本。

Now read: This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses

現在閱讀:這家專注於大麻素的製藥公司預計2023年收入將同比增長50%,減少虧損

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論